Search details
1.
The Neuroscience of Drug Reward and Addiction.
Physiol Rev
; 99(4): 2115-2140, 2019 10 01.
Article
in English
| MEDLINE | ID: mdl-31507244
2.
Unique pharmacodynamic properties and low abuse liability of the µ-opioid receptor ligand (S)-methadone.
Mol Psychiatry
; 29(3): 624-632, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38145984
3.
Evaluation of [18F]fluoroestradiol and ChRERα as a gene expression PET reporter system in rhesus monkey brain.
Mol Ther
; 2024 May 24.
Article
in English
| MEDLINE | ID: mdl-38796702
4.
A tool for monitoring cell type-specific focused ultrasound neuromodulation and control of chronic epilepsy.
Proc Natl Acad Sci U S A
; 119(46): e2206828119, 2022 11 16.
Article
in English
| MEDLINE | ID: mdl-36343238
5.
Effect of Selective Lesions of Nucleus Accumbens µ-Opioid Receptor-Expressing Cells on Heroin Self-Administration in Male and Female Rats: A Study with Novel Oprm1-Cre Knock-in Rats.
J Neurosci
; 43(10): 1692-1713, 2023 03 08.
Article
in English
| MEDLINE | ID: mdl-36717230
6.
Author Correction: Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours.
Nature
; 558(7710): E1, 2018 06.
Article
in English
| MEDLINE | ID: mdl-29769713
7.
Target deconvolution studies of (2R,6R)-hydroxynorketamine: an elusive search.
Mol Psychiatry
; 27(10): 4144-4156, 2022 10.
Article
in English
| MEDLINE | ID: mdl-35768639
8.
Enabling, Decagram-Scale Synthesis of Macrocyclic MCL-1 Inhibitor ABBV-467.
J Org Chem
; 88(22): 15562-15568, 2023 11 17.
Article
in English
| MEDLINE | ID: mdl-37909857
9.
Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours.
Nature
; 550(7674): 128-132, 2017 10 05.
Article
in English
| MEDLINE | ID: mdl-28953875
10.
Chemogenetics as a neuromodulatory approach to treating neuropsychiatric diseases and disorders.
Mol Ther
; 30(3): 990-1005, 2022 03 02.
Article
in English
| MEDLINE | ID: mdl-34861415
11.
Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability.
Mol Psychiatry
; 26(11): 6704-6722, 2021 11.
Article
in English
| MEDLINE | ID: mdl-33859356
12.
Evidence in primates supporting the use of chemogenetics for the treatment of human refractory neuropsychiatric disorders.
Mol Ther
; 29(12): 3484-3497, 2021 12 01.
Article
in English
| MEDLINE | ID: mdl-33895327
13.
Designer Receptors Exclusively Activated by Designer Drugs Approach to Treatment of Sleep-disordered Breathing.
Am J Respir Crit Care Med
; 203(1): 102-110, 2021 01 01.
Article
in English
| MEDLINE | ID: mdl-32673075
14.
Striatal Rgs4 regulates feeding and susceptibility to diet-induced obesity.
Mol Psychiatry
; 25(9): 2058-2069, 2020 09.
Article
in English
| MEDLINE | ID: mdl-29955167
15.
Discovery of spirohydantoins as selective, orally bioavailable inhibitors of p300/CBP histone acetyltransferases.
Bioorg Med Chem Lett
; 39: 127854, 2021 05 01.
Article
in English
| MEDLINE | ID: mdl-33631370
16.
The Kinase Chemogenomic Set (KCGS): An Open Science Resource for Kinase Vulnerability Identification.
Int J Mol Sci
; 22(2)2021 Jan 08.
Article
in English
| MEDLINE | ID: mdl-33429995
17.
Nucleus Accumbens Drd1-Expressing Neurons Control Aggression Self-Administration and Aggression Seeking in Mice.
J Neurosci
; 39(13): 2482-2496, 2019 03 27.
Article
in English
| MEDLINE | ID: mdl-30655356
18.
Ultrastructural localization of DREADDs in monkeys.
Eur J Neurosci
; 50(5): 2801-2813, 2019 09.
Article
in English
| MEDLINE | ID: mdl-31063250
19.
The SUV4-20 inhibitor A-196 verifies a role for epigenetics in genomic integrity.
Nat Chem Biol
; 13(3): 317-324, 2017 03.
Article
in English
| MEDLINE | ID: mdl-28114273
20.
The show must go on. Reply to "Distinct functions of S-ketamine and R-ketamine in mediating biobehavioral processes of drug dependency: comments on Bonaventura et al" by Insop Shim.
Mol Psychiatry
; 2022 Jun 22.
Article
in English
| MEDLINE | ID: mdl-35732692